New data show ReNeuron's lead CTX cell therapy candidate can be re-programmed into a pluripotent state and differentiated into other cell types
These new cell types can be efficiently expanded as potential cell therapy candidates targeting a broad range of diseases
PR Newswire
PENCOED, Wales, Oct. 23, 2019